Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

1 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 1000

Schizokinen and its analogues - MS2 - molecular networking

ABSTRACT: MS2 experiments with 3 CE: 10, 20, 30 eV for schizokinen derivatives, schizokinen, schizokinen A, N-deoxy-schizokinen and N-deoxy-schizokinen A

INSTRUMENT(S): 6530A Q-TOF LC/MS

ORGANISM(S): Schizokinen Derivatives Ms2

SUBMITTER: Prof. Dr. Lena Daumann

PROVIDER: MSV000088674 | MassIVE | Wed Jan 12 04:57:00 GMT 2022

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

GNPS Schizokinen and its analogues - MS2 - molecular networking

Project description:MS2 experiments with 3 CE: 10, 20, 30 eV for schizokinen derivatives, schizokinen, schizokinen A, N-deoxy-schizokinen and N-deoxy-schizokinen A

2022-01-12 | MSV000088674 | GNPS

MS2-affinity purification coupled with RNA sequencing (MAPS) reveals RybB sRNA targetome

Project description:Despite the overwhelming information about sRNAs, one of the biggest challenges in the sRNA field is characterizing sRNA targetomes. Thus, we develop a novel method to identify RNAs that interact with a specific sRNA, regardless of the type of regulation (positive or negative) or targets (mRNA, tRNA, sRNA). This method is called MAPS: MS2 affinity purification coupled with RNA sequencing. As proof of principle, we identified RNAs bound to RybB, a well-characterized E. coli sRNA. Identification of RNAs co-purified with MS2-RybB in a rne131 ΔrybB strain. RybB (without MS2) was used as control

2015-04-16 | E-GEOD-66518 | biostudies-arrayexpress

MS2-affinity purification coupled with RNA sequencing (MAPS) reveals RyhB sRNA targetome

Project description:Despite the overwhelming information about sRNAs, one of the biggest challenges in the sRNA field is characterizing sRNA targetomes. Thus, we develop a novel method to identify RNAs that interact with a specific sRNA, regardless of the type of regulation (positive or negative) or targets (mRNA, tRNA, sRNA). This method is called MAPS: MS2 affinity purification coupled with RNA sequencing. As proof of principle, we identified RNAs bound to RyhB, a well-characterized E. coli sRNA. Identification of RNAs co-purified with MS2-RyhB in a rne131 ?ryhB strain. RyhB (without MS2) was used as control

2015-04-16 | E-GEOD-66519 | biostudies-arrayexpress

Agrobacterium sp. MS2

Project description:Agrobacterium sp. MS2 Genome sequencing and assembly

| PRJNA476223 | ENA

MS2-affinity purification coupled with RNA sequencing (MAPS) reveals S. aureus RsaG sRNA targetome

Project description:MS2-affinity purification coupled with RNA sequencing (MAPS) reveals S. aureus RsaG sRNA targetome. Affinity purification of in vivo regulatory complexes coupled with high throughput RNA sequencing methodology or MAPS standing for “MS2 affinity purification coupled to RNA".

2024-06-01 | GSE176028 | GEO

Optimization of LC-MS2 Data Acquisition Parameters for Molecular Networking Applied to Marine Natural Products.

Project description: Not available

| S-EPMC8953742 | biostudies-literature

Highly efficient in vivo delivery of functional RNAs using new versatile MS2-chimeric retrovirus-like particles

Project description:RNA delivery is a method of choice to achieve transient gene expression for research and in cell- or gene-based therapies. To improve retroviral transfer, we designed a dimerization-independent MS2-driven packaging system using MS2-retrovirus chimeras. We delivered RUNX2- or DLX5-mRNA into primary human bone-marrow mesenchymal-stem-cells. We used microarrays to detail the global programme of gene expression confirming the effects of pro-osteogenic genes transduced by MS2 chimeric lentiviral particles.

2015-03-11 | GSE66723 | GEO

Dickeya zeae strain:MS2

Project description:Dickeya zeae strain:MS2 Raw sequence reads

| PRJNA1096148 | ENA

Global transcriptional responses to KI-MS2-008 treatment and Myc inactivation via doxycycline addition

Project description:The Myc/Max heterodimer has crucial roles in normal cellular processes such as cell proliferation, metabolism, apoptosis, and differentiation, but its activity is often deregulated in a majority of human cancers. In an effort to explore alternative modes of Myc perturbation, we identified KI-MS2-008 as a small molecule that binds Max and modulates Myc-driven transcription, and in some cellular contexts, KI-MS2-008 treatment leads to a decrease in c-Myc protein levels. As the Myc/Max heterodimer controls many cellular processes, we expected that treatment with this small molecule would cause changes in the transcriptome. We found that treatment with 10 µM KI-MS2-008 resulted in global alterations in the transcriptome, mimicking direct Myc inactivation with doxycycline in P493-6, a B cell line with a Tet-Off system for c-Myc expression. We also discovered enrichment of various Myc target gene sets in the genes downregulated in response to KI-MS2-008 treatment in P493-6 cells. This trend was also observed in ST486 cells, but not in P3HR1 cells, which were chosen as non-engineered B cell lines that were sensitive and insensitive, respectively, toward KI-MS2-008 in cell viability assays.

2019-03-14 | GSE107222 | GEO

Dickeya zeae strain:MS2

Project description:Dickeya zeae strain:MS2 Genome sequencing and assembly

| PRJNA429264 | ENA